METN Stock Overview
Through its subsidiaries, engages in the medical devices, infection control, technology cluster and infrastructure, and other businesses in Switzerland, rest of Europe, the Americas, the Asia Pacific, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Metall Zug AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 1,190.00 |
| 52 Week High | CHF 1,570.00 |
| 52 Week Low | CHF 1,175.00 |
| Beta | 0.98 |
| 11 Month Change | -1.24% |
| 3 Month Change | -4.80% |
| 1 Year Change | -7.03% |
| 33 Year Change | -41.67% |
| 5 Year Change | -38.82% |
| Change since IPO | -62.09% |
Recent News & Updates
Recent updates
Should You Think About Buying Metall Zug AG (VTX:METN) Now?
Jun 18
Metall Zug's (VTX:METN) Weak Earnings May Only Reveal A Part Of The Whole Picture
Mar 18Does Metall Zug (VTX:METN) Deserve A Spot On Your Watchlist?
Aug 16With EPS Growth And More, Metall Zug (VTX:METN) Makes An Interesting Case
Mar 16Is Now An Opportune Moment To Examine Metall Zug AG (VTX:METN)?
Jun 03Metall Zug (VTX:METN) Is Paying Out A Larger Dividend Than Last Year
Apr 30Metall Zug (VTX:METN) Will Pay A Larger Dividend Than Last Year At CHF30.00
Apr 16Metall Zug (VTX:METN) Will Pay A Larger Dividend Than Last Year At CHF30.00
Mar 23Metall Zug (VTX:METN) Takes On Some Risk With Its Use Of Debt
Dec 13Metall Zug (VTX:METN) Takes On Some Risk With Its Use Of Debt
Sep 11Metall Zug (VTX:METN) Has Some Difficulty Using Its Capital Effectively
May 29Is It Time To Consider Buying Metall Zug AG (VTX:METN)?
May 14Results: Metall Zug AG Beat Earnings Expectations And Analysts Now Have New Forecasts
Mar 21Is Metall Zug AG (VTX:METN) A Good Dividend Stock?
Mar 02Should You Investigate Metall Zug AG (VTX:METN) At CHF1,640?
Feb 09Should You Use Metall Zug's (VTX:METN) Statutory Earnings To Analyse It?
Jan 22Is Metall Zug (VTX:METN) Headed For Trouble?
Jan 07
Could The Metall Zug AG (VTX:METN) Ownership Structure Tell Us Something Useful?
Dec 22Is The Market Looking Unfavorably At Metall Zug AG's (VTX:METN) Inconsistent Fundamentals?
Dec 10If You Had Bought Metall Zug (VTX:METN) Shares Three Years Ago You'd Have A Total Return Of Negative 35%
Nov 26Shareholder Returns
| METN | CH Medical Equipment | CH Market | |
|---|---|---|---|
| 7D | -0.4% | 0.02% | 1.4% |
| 1Y | -7.0% | 26.4% | 15.5% |
Return vs Industry: METN underperformed the Swiss Medical Equipment industry which returned 26.4% over the past year.
Return vs Market: METN underperformed the Swiss Market which returned 15.5% over the past year.
Price Volatility
| METN volatility | |
|---|---|
| METN Average Weekly Movement | 2.5% |
| Medical Equipment Industry Average Movement | 3.8% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 7.3% |
| 10% least volatile stocks in CH Market | 1.5% |
Stable Share Price: METN has not had significant price volatility in the past 3 months compared to the Swiss market.
Volatility Over Time: METN's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1887 | 990 | Matthias Rey | www.metallzug.ch |
Metall Zug AG, through its subsidiaries, engages in the medical devices, infection control, technology cluster and infrastructure, and other businesses in Switzerland, rest of Europe, the Americas, the Asia Pacific, and internationally. The company offers medical and surgical instrument sterilization, disinfection, and cleaning product and service solutions. It also develops, produces, and distributes devices and solutions for medical diagnosis, microsurgery, and eye care specialist; and offers diagnostics equipment, such as slit lamps, perimetry, and biometry for cataract diagnosis and treatment; equipment for ophthalmologists, including stands, chairs, industrial high-precision surgical microscopes, and other accessories; and augmented reality technology and digital imaging for the eye care specialists.
Metall Zug AG Fundamentals Summary
| METN fundamental statistics | |
|---|---|
| Market cap | CHF 535.50m |
| Earnings (TTM) | CHF 68.51m |
| Revenue (TTM) | CHF 447.48m |
7.8x
P/E Ratio1.2x
P/S RatioIs METN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| METN income statement (TTM) | |
|---|---|
| Revenue | CHF 447.48m |
| Cost of Revenue | CHF 314.05m |
| Gross Profit | CHF 133.43m |
| Other Expenses | CHF 64.93m |
| Earnings | CHF 68.51m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 24, 2025
| Earnings per share (EPS) | 152.23 |
| Gross Margin | 29.82% |
| Net Profit Margin | 15.31% |
| Debt/Equity Ratio | 8.9% |
How did METN perform over the long term?
See historical performance and comparison